Skip to main content

Texas Researchers to Use Bioserve Bank to Link Genes to Thoracic Aortic Disease

NEW YORK (GenomeWeb News) — The Specialized Clinical Center of Research in Houston will use Bioserve’s Global Repository to study genetic links to thoracic aortic disease, Bioserve said today.
 
Bioserve said it will provide the SCCOR with access to “certain unique sample sets” from the company’s repository, which includes 600,000 DNA, tissue, and serum samples along with clinical and demographic data.  
 
The SCCOR program is a collaborative effort of the University of Texas Health Science Center Houston, Baylor College of Medicine, and the University of Texas Medical Branch.
 
The company said the SCCOR will use the samples to look for genes that can predict the development and progression of thoracic aortic diseases.
 
The SCCOR study is funded by a five-year grant from the National Heart, Lung and Blood Institute.
 
Financial terms of the agreement were not released.

The Scan

Possibly as Transmissible

Officials in the UK say the B.1.617.2 variant of SARS-CoV-2 may be as transmitted as easily as the B.1.1.7 variant that was identified in the UK, New Scientist reports.

Gene Therapy for SCID 'Encouraging'

The Associated Press reports that a gene therapy appears to be effective in treating severe combined immunodeficiency syndrome.

To Watch the Variants

Scientists told US lawmakers that SARS-CoV-2 variants need to be better monitored, the New York Times reports.

Nature Papers Present Nautilus Genome, Tool to Analyze Single-Cell Data, More

In Nature this week: nautilus genome gives peek into its evolution, computational tool to analyze single-cell ATAC-seq data, and more.